Vanguard Global Advisers’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.59M Buy
234,776
+39,333
+20% +$1.43M ﹤0.01% 649
2026
Q2
$6.92M Sell
195,443
-12,265
-6% -$362K ﹤0.01% 701
2026
Q1
$5.75M Buy
+207,708
New +$5.34M ﹤0.01% 720

Other funds holding ROIV

Vanguard Global Advisers's ROIV Position: Q3 2026 in Review

Vanguard Global Advisers increased its Roivant Sciences (ROIV) stake by 20% in Q3 2026, buying an estimated $1.43M and bringing the position to 234,776 shares worth $8.59M. The position accounts for ﹤0.01% of the portfolio, ranked #649.

Vanguard Global Advisers first reported a position in ROIV in Q1 2026 and has held it in 3 quarters since. 522 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Vanguard Global Advisers held 234,776 shares of Roivant Sciences worth $8.59M as of Q3 2026.
  • Vanguard Global Advisers bought 39,333 Roivant Sciences shares in Q3 2026, an estimated $1.43M.
  • Roivant Sciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #649 holding.
  • Vanguard Global Advisers first reported a position in Roivant Sciences in Q1 2026 and has held it in 3 quarters since.
  • 522 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.